logo
[breadcrumb_custom]

Tag: (ENVB)

News

ENVB’s Stock Market Odyssey: A Year of Growth, Decline, and Resilience

The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. Year to date metric has recorded a loss of -12.31%.However, over the last six months, we can see a stronger performance of -52.10%. Over the last 30 days, the price of ENVB has leaped by -31.33%. And in the last five days, it has surged by 8.57%. Enveric Biosciences Inc’s stock market performance has been somewhat irregular. The 1-year high for the company’s stock was recorded at $6.98 on 05/24/23,

AMZN
Stock

ENVB’s Stock Market Adventure: -23.08% YTD Growth Amidst Volatility

Investors’ outlook regarding the stock price performance over the year has been split, with some feeling optimistic and others feeling pessimistic, as it’s been a mixed bag. The metric has seen a significant loss of -23.08% since the start of this calendar year. Looking back over the last six months, we can see a stronger performance of -56.71%. Over the past 30 days, the price of ENVB has fallen by 20.34%. And in the last five days, it has fallen by -14.53%. Enveric Biosciences Inc saw a rather unpredictable run in, in terms of market performance. The company’s stock reached

Finance

Enveric Biosciences Inc (ENVB) Stock: A Year of Highs and Lows

Examining a stock’s 52-week price history, encompassing its low and high prices, can reveal much about its existing condition and potential future trajectory. Enveric Biosciences Inc’s current trading price is -82.38% away from its 52-week high, while its distance from the 52-week low is 89.52%. The stock’s price range over this period has fluctuated between $0.65 and $6.98. The company, operating within the financial sector, had a trading volume of approximately 46.16 million for the day, which was noticeably higher than the average daily share volume of 3.54 million over the last 3 months. Enveric Biosciences Inc saw a rather

OPEN Stock
Stock

Enveric Biosciences Inc: Weathering Stock Market Storms with 3.29M Market Cap

Enveric Biosciences Inc’s market performance has been unstable in recent times. The company’s stock hit a 1-year high of $6.98 on 05/24/23 and a low of $0.65 for the same time frame on 02/01/24. 52-week price history of ENVB Stock Studying a stock’s 52-week price history, which includes both low and high prices, can help gauge its current status and potential future performance. Enveric Biosciences Inc’s current trading price is -82.81% away from its 52-week high, while its distance from the 52-week low is 84.90%. The stock’s price range during the 52-week period has remained between $0.65 and $6.98. In

Finance

Enveric Biosciences Inc Inc. (ENVB) Price Performance: The Role of Share Buybacks and Stock Splits

The stock price performance over the year has been a mixed bag, resulting in a range of outlooks from optimistic to pessimistic depending on the observer. Year to date metric has recorded a gain of 27.69%.However, over the last six months, we can see a stronger performance of -24.89%. Over the last 30 days, the price of ENVB has fallen by 123.72%. And in the last five days, it has surged by 69.39%. In terms of market performance, Enveric Biosciences Inc had a fairly uneven. The highest value for the stock in the past year was $6.98 on 05/24/23, and

Finance

ENVB Stock: Exploring Enveric Biosciences Inc’s Growth

Enveric Biosciences Inc experienced a somewhat shaky performance in the stock market. The company’s stock reached a 1-year high of $6.98 on 05/24/23, while the lowest price for the same period was registered at $0.65 on 02/01/24. 52-week price history of ENVB Stock A stock’s 52-week high and low prices can reveal much about its current status and future trajectory. Enveric Biosciences Inc’s current trading price is -72.57% away from its 52-week high, while its distance from the 52-week low is 195.01%. The stock’s price range during this period has spanned from $0.65 to $6.98. In the Healthcare sector, the